Rev1 Ventures, a Columbus, Ohio-based venture capital firm and startup studio, launched a $15m fund.
Backed by The Ohio State University and Nationwide Children’s Hospital, the $15MM Rev1 Catalyst Fund II aims to back life sciences companies (spinouts and healthcare innovators) advancing research-based healthcare innovation.
The fund was founded on the results of the Rev1 Life Sciences Fund I, which supports a portfolio of companies driving the creation of innovative therapies and solutions, and has generated more than $250MM in exits, including the recent acquisitions of Celenex and Myonexus.
Led by Tom Walker, president and CEO, Rev1 Ventures Rev1 Ventures is an investor startup studio that combines capital and strategic services to allow startups to scale and corporates to innovate.
The firm has $100MM in capital under management.